"There's nobody who looks at the healthcare system or the pharmaceutical industry and says ‘wow, that’s well run.'" ...
At the Fortune Brainstorm Tech Dinner in Las Vegas, Fortune's Andrew Nusca interviews Mark Cuban about his work with Cost Plus Drugs. Cuban discusses disrupting the pharmaceutical industry, tackling ...
Billionaire investor and businessman Mark Cuban recently met with leaders at Penn Medicine, including University of Pennsylvania Health System CEO Kevin Mahoney (left) and Penn Medicine vice president ...
Mark Cuban is making his Cost Plus Drug Co. online pharmacy and discount card program a test of the proposition that the U.S. prescription drug market is just another market. Pramod John ...
Plus Oceans Healthcare adds five states with acquisition and UTA professor leads $1.8 million study.
Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...
Nearly three years after its launch, Mark Cuban Cost Plus Drug Co. now manufactures injectables in shortage, works with thousands of healthcare facilities, including pharmacies, hospitals ...
American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that ...
As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...
thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are ...
Cuban designed his pharmaceutical company, Cost Plus Drugs, to provide medications at ... cover – it changes in a nanosecond," he said. Mark Cuban's ideas challenge the status quo and offer ...
Mark Cuban focuses on disruptive tech and avoids ... Pharmaceuticals: Cuban launched the Cost Plus Drug Company in early 2022 with the mission of lowering the prices of generic drugs for U.S ...